Published in Clin J Am Soc Nephrol on July 15, 2010
Mortality and cardiovascular disease among older live kidney donors. Am J Transplant (2014) 2.16
The decline in living kidney donation in the United States: random variation or cause for concern? Transplantation (2013) 1.86
Association of metabolic syndrome with kidney function and histology in living kidney donors. Am J Transplant (2013) 1.63
Reimbursement for living kidney donor follow-up care: how often does donor insurance pay? Transplantation (2012) 1.39
Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors. Transplantation (2014) 1.22
Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades. Am J Transplant (2012) 1.19
Risks and outcomes of living donation. Adv Chronic Kidney Dis (2012) 1.12
Target organ damage in African American hypertension: role of APOL1. Curr Hypertens Rep (2012) 1.02
Kidney transplant outcomes for prior living organ donors. J Am Soc Nephrol (2014) 0.96
Living donor practices in the United States. Adv Chronic Kidney Dis (2012) 0.96
Living-Donor Kidney Transplantation: Reducing Financial Barriers to Live Kidney Donation--Recommendations from a Consensus Conference. Clin J Am Soc Nephrol (2015) 0.90
Comorbidity burden and perioperative complications for living kidney donors in the United States. Clin J Am Soc Nephrol (2013) 0.89
Experiences obtaining insurance after live kidney donation. Am J Transplant (2014) 0.86
Living Donor Kidney Transplantation: Facilitating Education about Live Kidney Donation--Recommendations from a Consensus Conference. Clin J Am Soc Nephrol (2015) 0.84
Creatinine-based estimations of kidney function are unreliable in obese kidney donors. J Transplant (2012) 0.84
Cancer diagnoses after living kidney donation: linking U.S. Registry data and administrative claims. Transplantation (2012) 0.84
Better understanding live donor risk through big data. Clin J Am Soc Nephrol (2013) 0.81
Lack of health insurance in living kidney donors. Clin Transplant (2011) 0.79
The living kidney donor evaluation: focus on renal issues. Clin J Am Soc Nephrol (2012) 0.78
A moral dilemma argument against clinical trials of incentives for kidney donation. Transplant Res (2015) 0.75
Living Kidney Donors Who Develop Kidney Failure: Excerpts of Their Thoughts. Am J Nephrol (2016) 0.75
Profiling live kidney donors in America: cause for optimism and for concern. Clin J Am Soc Nephrol (2010) 0.75
Health Insurance Trends in United States Living Kidney Donors (2004 to 2015). Am J Transplant (2016) 0.75
Long-term consequences of kidney donation. N Engl J Med (2009) 10.17
MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet (2008) 9.50
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet (2008) 9.00
The epidemiology of obesity. Gastroenterology (2007) 8.35
Body mass index and risk for end-stage renal disease. Ann Intern Med (2006) 7.56
Blood pressure and end-stage renal disease in men. N Engl J Med (1996) 5.68
Obesity among adults in the United States--no statistically significant change since 2003-2004. NCHS Data Brief (2007) 4.99
Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med (2006) 4.32
Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol (2003) 4.28
20 years or more of follow-up of living kidney donors. Lancet (1992) 3.88
Proteinuria and the risk of developing end-stage renal disease. Kidney Int (2003) 3.73
Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int (2009) 3.58
Estimating kidney function in adults using formulae. Ann Clin Biochem (2005) 3.28
The medical evaluation of living kidney donors: a survey of US transplant centers. Am J Transplant (2007) 3.12
Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis (2004) 3.11
Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol (2002) 2.96
Morbidity and mortality after living kidney donation, 1999-2001: survey of United States transplant centers. Am J Transplant (2003) 2.95
Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med (2005) 2.90
Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation (2002) 2.86
Pregnancy outcomes after kidney donation. Am J Transplant (2009) 2.66
Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. J Am Soc Nephrol (2006) 2.32
Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation (2004) 2.22
Preemptive kidney transplantation: the advantage and the advantaged. J Am Soc Nephrol (2002) 2.19
Incidence of end-stage renal disease among live kidney donors. Transplantation (2006) 2.13
Living kidney donors requiring transplantation: focus on African Americans. Transplantation (2007) 1.92
Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada. Transplantation (2008) 1.83
Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study. Am J Nephrol (2009) 1.80
The link between hypertension and nephrosclerosis. Am J Kidney Dis (1995) 1.77
Long-term (20-37 years) follow-up of living kidney donors. Am J Transplant (2002) 1.70
Pregnancy and birth after kidney donation: the Norwegian experience. Am J Transplant (2008) 1.69
Living kidney donors in need of kidney transplants: a report from the organ procurement and transplantation network. Transplantation (2002) 1.65
The performance of three serum creatinine-based formulas in estimating GFR in former kidney donors. Am J Transplant (2006) 1.60
Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension (1995) 1.58
Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers. Am J Transplant (2008) 1.57
Primum non Nocere: is chronic kidney disease staging appropriate in living kidney transplant donors? Am J Transplant (2009) 1.49
Evaluation of living renal donors. The current practice of US transplant centers. Transplantation (1995) 1.47
Renal outcome 25 years after donor nephrectomy. J Urol (2001) 1.47
Risk of live kidney donation--Indian perspective. J Assoc Physicians India (2007) 1.44
Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study. Hypertension (2009) 1.26
Trends in treatment and outcomes of survival of adolescents initiating end-stage renal disease care in the United States of America. Pediatr Nephrol (2006) 1.23
Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. Kidney Int (1997) 1.21
Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clin Exp Nephrol (2008) 1.19
The Living Organ Donor Network: a model registry for living kidney donors. Clin Transplant (2004) 1.12
A study of renal outcomes in African American living kidney donors. Transplantation (2009) 1.09
Preemptive transplantation for patients with diabetes-related kidney disease. Arch Intern Med (2006) 1.07
Nephrectomy elicits impact of age and BMI on renal hemodynamics: lower postdonation reserve capacity in older or overweight kidney donors. Am J Transplant (2008) 1.06
Can spot urine protein/creatinine ratio replace 24 h urine protein in usual clinical nephrology? Nephrology (Carlton) (2006) 1.05
Insurance status of U.S. organ donors and transplant recipients: the uninsured give, but rarely receive. Int J Health Serv (2008) 1.03
Time-zero renal biopsy in living kidney transplantation: a valuable opportunity to correlate predonation clinical data with histological abnormalities. Transplantation (2008) 1.00
The evaluation and selection of living kidney donors. Am J Kidney Dis (1995) 0.93
Risk of developing low glomerular filtration rate or elevated serum creatinine in a screened cohort in Okinawa, Japan. Hypertens Res (2007) 0.90
Long-term follow-up of living kidney donors: a longitudinal study. BJU Int (2007) 0.89
Body mass index and the risk of chronic renal failure: the Asian experience. Contrib Nephrol (2006) 0.88
Comparison between 24-h proteinuria, urinary protein/creatinine ratio and dipstick test in patients with nephropathy: patterns of proteinuria in dipstick-negative patients. Scand J Clin Lab Invest (2006) 0.86
High-normal blood pressure and the risk of cardiovascular disease. Circ J (2009) 0.84
Blood pressure and risk of end-stage renal disease in a screened cohort. Kidney Int Suppl (1996) 0.82
Obesity is associated with family history of ESRD in incident dialysis patients. Am J Kidney Dis (2006) 0.80
Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant (2004) 2.22
Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation. JAMA (2005) 2.15
Living kidney donor follow-up: state-of-the-art and future directions, conference summary and recommendations. Am J Transplant (2011) 1.51